210 related articles for article (PubMed ID: 34328632)
1. Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data.
Kareva I; Zutshi A; Mateo CV; Papasouliotis O
Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):601-611. PubMed ID: 34328632
[TBL] [Abstract][Full Text] [Related]
2. Infection Phenotypes Among Patients with Primary Antibody Deficiency Mined from a US Patient Registry.
Pickett G; Motazedi T; Kutac C; Cahill G; Cunnigham-Rundles C; Fuleihan RL; Sullivan KE; Rider NL
J Clin Immunol; 2021 Feb; 41(2):374-381. PubMed ID: 33205244
[TBL] [Abstract][Full Text] [Related]
3. [Antibodydeficiencies Epidemiology, Clinical manifestation, Diagnostics and Therapy].
Jandus P; Bitzenhofer-Grüber M
Ther Umsch; 2022 Aug; 79(6):279-283. PubMed ID: 35903831
[TBL] [Abstract][Full Text] [Related]
4. Immunological and Clinical Phenotyping in Primary Antibody Deficiencies: a Growing Disease Spectrum.
Shin JJ; Liauw D; Siddiqui S; Lee J; Chung EJ; Steele R; Hsu FI; Price C; Kang I
J Clin Immunol; 2020 May; 40(4):592-601. PubMed ID: 32239366
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors of Pneumonia in Primary Antibody Deficiency Patients Receiving Immunoglobulin Therapy: Data from the US Immunodeficiency Network (USIDNET).
Syed MN; Kutac C; Miller JM; Marsh R; Sullivan KE; Cunningham-Rundles C; Fuleihan RL; Kheradmand F; Hajjar J
J Clin Immunol; 2022 Oct; 42(7):1545-1552. PubMed ID: 35779201
[TBL] [Abstract][Full Text] [Related]
7. Delayed Diagnosis and Complications of Predominantly Antibody Deficiencies in a Cohort of Australian Adults.
Slade CA; Bosco JJ; Binh Giang T; Kruse E; Stirling RG; Cameron PU; Hore-Lacy F; Sutherland MF; Barnes SL; Holdsworth S; Ojaimi S; Unglik GA; De Luca J; Patel M; McComish J; Spriggs K; Tran Y; Auyeung P; Nicholls K; O'Hehir RE; Hodgkin PD; Douglass JA; Bryant VL; van Zelm MC
Front Immunol; 2018; 9():694. PubMed ID: 29867917
[TBL] [Abstract][Full Text] [Related]
8. Cellular immune response to SARS-CoV-2 in patients with primary antibody deficiencies.
Mizera D; Dziedzic R; Drynda A; Gradzikiewicz A; Jakieła B; Celińska-Löwenhoff M; Padjas A; Matyja-Bednarczyk A; Zaręba L; Bazan-Socha S
Front Immunol; 2023; 14():1275892. PubMed ID: 37901210
[TBL] [Abstract][Full Text] [Related]
9. Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases.
Ballow M; Sánchez-Ramón S; Walter JE
Front Immunol; 2022; 13():928062. PubMed ID: 35924244
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary Manifestations of Immunodeficiency and Immunosuppressive Diseases Other than Human Immunodeficiency Virus.
Pacheco SE; Stark JM
Pediatr Clin North Am; 2021 Feb; 68(1):103-130. PubMed ID: 33228927
[TBL] [Abstract][Full Text] [Related]
11. Application of Flow Cytometry in Predominantly Antibody Deficiencies.
Yazdani R; Aghamohammadi A; Rezaei N
Endocr Metab Immune Disord Drug Targets; 2021; 21(4):647-663. PubMed ID: 32693771
[TBL] [Abstract][Full Text] [Related]
12. Serum B-Cell Maturation Antigen (BCMA) Levels Differentiate Primary Antibody Deficiencies.
Maglione PJ; Ko HM; Tokuyama M; Gyimesi G; Soof C; Li M; Sanchez E; Chen H; Radigan L; Berenson J; Cunningham-Rundles C
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):283-291.e1. PubMed ID: 31430592
[TBL] [Abstract][Full Text] [Related]
13. Good's syndrome: brief overview of an enigmatic immune deficiency.
Sipos F; Műzes G
APMIS; 2023 Dec; 131(12):698-704. PubMed ID: 37729389
[TBL] [Abstract][Full Text] [Related]
14. Endocrine Disorders Are Prominent Clinical Features in Patients With Primary Antibody Deficiencies.
Coopmans EC; Chunharojrith P; Neggers SJCMM; van der Ent MW; Swagemakers SMA; Hollink IH; Barendregt BH; van der Spek PJ; van der Lely AJ; van Hagen PM; Dalm VASH
Front Immunol; 2019; 10():2079. PubMed ID: 31543881
[No Abstract] [Full Text] [Related]
15. The Clinical and Immunological Features of Patients with Primary Antibody Deficiencies.
Azizi G; Bagheri Y; Tavakol M; Askarimoghaddam F; Porrostami K; Rafiemanesh H; Yazdani R; Kiaee F; Habibi S; Abouhamzeh K; Mohammadi H; Qorbani M; Abolhassani H; Aghamohammadi A
Endocr Metab Immune Disord Drug Targets; 2018; 18(5):537-545. PubMed ID: 29651973
[TBL] [Abstract][Full Text] [Related]
16. Update on Infections in Primary Antibody Deficiencies.
Demirdag YY; Gupta S
Front Immunol; 2021; 12():634181. PubMed ID: 33643318
[TBL] [Abstract][Full Text] [Related]
17. Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies.
Blanco E; Pérez-Andrés M; Arriba-Méndez S; Serrano C; Criado I; Del Pino-Molina L; Silva S; Madruga I; Bakardjieva M; Martins C; Serra-Caetano A; Romero A; Contreras-Sanfeliciano T; Bonroy C; Sala F; Martín A; Bastida JM; Lorente F; Prieto C; Dávila I; Marcos M; Kalina T; Vlkova M; Chovancova Z; Cordeiro AI; Philippé J; Haerynck F; López-Granados E; Sousa AE; van der Burg M; van Dongen JJM; Orfao A;
J Allergy Clin Immunol; 2019 Sep; 144(3):809-824. PubMed ID: 30826363
[TBL] [Abstract][Full Text] [Related]
18. [Autoimmune disease in primary antibody deficiencies].
Sarmiento E; Mora R; Rodríguez-Mahou M; Rodríguez-Molina J; Fernández-Cruz E; Carbone J
Allergol Immunopathol (Madr); 2005; 33(2):69-73. PubMed ID: 15808112
[TBL] [Abstract][Full Text] [Related]
19. Correction to: Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data.
Kareva I; Zutshi A; Mateo CV; Papasouliotis O
Eur J Drug Metab Pharmacokinet; 2021 Nov; 46(6):827. PubMed ID: 34581976
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
